Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

N/AActive Not RecruitingNCT01514669

University of Arkansas75 enrolled

Overview

The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Prostate Cancer

Eligibility

Sex: MALEMin age: 35 YearsMax age: 85 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male, 35-85 years old 2. Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.) 3. Patients who present for the evaluation of a palpable nodule or induration on prostate exam 4. Patients who meet the requirements of Group 1, 2, or 3 of the protocol Exclusion Criteria: 1. Patient \< 35 or \> 85 years of age 2. Concurrent eye infection or trauma, including active conjunctivitis 3. Abnormal production of tears (too much or too little) 4. Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment 5. Atypia on prostate biopsy report

Locations (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

Outcomes

Primary Outcomes

Tear Sample

Tear sample will be taken at the initial clinic visit

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.